HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

New father who was run over by surgeon describes distress of having part of his head missing

Raiders use digger in attempt to steal safe from McDonald's

Key questions after European Court dismisses Ireland's claim 'Hooded Men' suffered torture

Search intensifies for missing Elisha, 14

Today's Stories

Working poor rise despite economic recovery

Immigrant students more likely to be bullied

Brexit fallback deal on border is ‘legally firm’

Charlie Flanagan to discuss laundries report with Ombudsman


New father’s life ‘changed forever’ after he was run over by surgeon

The biggest cancer killer will take your breath away

Hopefully she had an idea...

Power of the press: Meryl Streep and Tom Hanks discuss 'The Post'

More From The Irish Examiner